MIT has announced a $100 million gift from Koch Industries executive and MIT alumnus David H. Koch that will usher in new paradigms in highly integrative cancer research. The gift will bring together MIT scientists and engineers under one roof to develop new and powerful ways to detect, diagnose, treat, and manage this often deadly disease.
A UNSW researcher has developed a world-first test which will radically improve cancer management. Professor Philip Hogg, the co-director of UNSW’s Lowy Cancer Research Centre, has developed the technology which will determine whether cancer cells are dying within one day of a patient’s treatment with radiation or chemotherapy.
The study is based on data of patients, treated in any of the 10 Andalusian public hospitals for one year, who were submitted to radiotherapy procedures for the treatment of tumours in the breast, lung, head and neck, cervix and endometrium.
A new study finds treatment for breast cancer differs between African-American women and white women, though the differences are partly dependent on insurance type. The study appears in the November 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
Researchers at Cold Spring Harbor Laboratory have discovered three genes that interact with cancerous results in 20 percent of lung cancers. The three genes are located next to each other on human chromosome 14 and two are known to play key roles in fetal lung development.
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects – and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.
In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone®.
There have been improvements in cancer survival in Northern Ireland between 1993 and 2004, according to a new report from the Northern Ireland Cancer Registry (NICR).
The PA Commission for Women turned the Point State Park Fountain bright pink, in observance of national Breast Cancer Awareness Month.